B. Coco

4.9k total citations · 1 hit paper
50 papers, 1.9k citations indexed

About

B. Coco is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, B. Coco has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 38 papers in Hepatology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in B. Coco's work include Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (29 papers) and Liver Disease Diagnosis and Treatment (27 papers). B. Coco is often cited by papers focused on Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (29 papers) and Liver Disease Diagnosis and Treatment (27 papers). B. Coco collaborates with scholars based in Italy, China and United States. B. Coco's co-authors include Maurizia Rossana Brunetto, Ferruccio Bonino, Filippo Oliveri, P. Colombatto, P. Ciccorossi, Rodolfo Sacco, A.M. Maina, V. Romagnoli, B. Cherubini and D. Cavallone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

B. Coco

47 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

2006 536 citations B. Coco, Filippo Oliveri et al. Journal of Viral Hepatitis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Coco Italy	15	1.7k	1.6k	109	106	100	50	1.9k
Rune Wejstål Sweden	23	1.8k 1.1×	1.9k 1.2×	113 1.0×	51 0.5×	100 1.0×	67	2.1k
G. Ronchi Italy	13	1.3k 0.8×	1.2k 0.8×	75 0.7×	261 2.5×	50 0.5×	37	1.6k
Valeria Piazzolla Italy	16	910 0.5×	861 0.6×	121 1.1×	58 0.5×	21 0.2×	43	1.1k
O Inoue Japan	13	909 0.5×	901 0.6×	34 0.3×	109 1.0×	50 0.5×	26	1.1k
Kazuhide Shimamatsu Japan	14	714 0.4×	693 0.4×	71 0.7×	258 2.4×	56 0.6×	33	1.1k
A. Petrarca Italy	13	1.4k 0.8×	1.4k 0.9×	88 0.8×	299 2.8×	52 0.5×	18	1.7k
Corinne Castelnau France	22	2.3k 1.4×	2.4k 1.5×	146 1.3×	33 0.3×	34 0.3×	43	2.6k
Nai‐Jen Hou Taiwan	16	917 0.5×	943 0.6×	65 0.6×	79 0.7×	20 0.2×	38	1.1k
Anne Bastie France	15	1.0k 0.6×	1.0k 0.7×	73 0.7×	75 0.7×	87 0.9×	28	1.3k
S. Maimone Italy	15	767 0.5×	731 0.5×	64 0.6×	150 1.4×	22 0.2×	45	963

Countries citing papers authored by B. Coco

Since Specialization

Citations

This map shows the geographic impact of B. Coco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Coco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Coco more than expected).

Fields of papers citing papers by B. Coco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Coco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Coco. The network helps show where B. Coco may publish in the future.

Co-authorship network of co-authors of B. Coco

This figure shows the co-authorship network connecting the top 25 collaborators of B. Coco. A scholar is included among the top collaborators of B. Coco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Coco. B. Coco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caviglia, Gian Paolo, Piero Fariselli, Roberta D’Ambrosio, et al.. (2024). Development and Validation of a PIVKA‐II‐Based Model for HCC Risk Stratification in Patients With HCV‐Related Cirrhosis Successfully Treated With DAA. Alimentary Pharmacology & Therapeutics. 61(3). 538–549. 2 indexed citations

Michelucci, Elena, Giovanni Signore, B. Coco, et al.. (2024). The Clinical Utility of the Saliva Proteome in Rare Diseases: A Pilot Study for Biomarker Discovery in Primary Sclerosing Cholangitis. Journal of Clinical Medicine. 13(2). 544–544. 1 indexed citations

Cavallone, D., G. Ricco, Filippo Oliveri, et al.. (2023). The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection. Viruses. 15(11). 2257–2257. 2 indexed citations

Floreani, Annarosa, B. Coco, Edoardo G. Giannini, et al.. (2022). Primary biliary cholangitis: perception and expectation of illness. Digestive and Liver Disease. 54(9). 1230–1233. 2 indexed citations

Ricco, G., B. Coco, P. Colombatto, et al.. (2022). Highly dynamic changes of regional HBV epidemiology over two decades. Digestive and Liver Disease. 55(4). 519–526. 10 indexed citations

Salvati, A, Francesco Faita, D. Cavallone, et al.. (2021). Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?. Hepatoma Research. 2021. 2 indexed citations

Boni, Carolina, Andrea Vecchi, Marzia Rossi, et al.. (2018). TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues. Gastroenterology. 154(6). 1764–1777.e7. 112 indexed citations

Sabini, Elena, Eleonora Sisti, B. Coco, et al.. (2016). Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves’ orbitopathy. Journal of Endocrinological Investigation. 39(11). 1323–1327. 8 indexed citations

Sisti, Eleonora, B. Coco, Francesca Menconi, et al.. (2015). Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy. Thyroid. 25(7). 846–850. 26 indexed citations

10.

Sisti, Eleonora, B. Coco, Francesca Menconi, et al.. (2015). Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study. European Journal of Endocrinology. 172(3). 269–276. 47 indexed citations

11.

Brunetto, Maurizia Rossana, D. Cavallone, Filippo Oliveri, et al.. (2014). A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection. PLoS ONE. 9(10). e110782–e110782. 38 indexed citations

12.

Brunetto, Maurizia Rossana, Filippo Oliveri, P. Colombatto, et al.. (2010). Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers. Gastroenterology. 139(2). 483–490. 305 indexed citations

13.

Bonino, Ferruccio, Umberto Arena, Maurizia Rossana Brunetto, et al.. (2010). Liver Stiffness, a Non-Invasive Marker of Liver Disease: A Core Study Group Report. Antiviral Therapy. 15(3_suppl). 69–78. 26 indexed citations

14.

Moriconi, F., P. Colombatto, B. Coco, et al.. (2007). Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. Journal of Antimicrobial Chemotherapy. 60(2). 341–349. 17 indexed citations

15.

Coco, B., Filippo Oliveri, P. Ciccorossi, et al.. (2006). 526 Liver stiffness measured by transient elastography. The influence of biochemical activity. Journal of Hepatology. 44. S196–S196. 8 indexed citations

16.

Coco, B., Filippo Oliveri, A.M. Maina, et al.. (2006). Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. Journal of Viral Hepatitis. 14(5). 360–369. 536 indexed citations breakdown →

17.

Brunetto, Maurizia Rossana, Filippo Oliveri, P. Colombatto, et al.. (2003). Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon. Journal of Hepatology. 39. 164–167. 28 indexed citations

18.

Brunetto, Maurizia Rossana, Filippo Oliveri, B. Coco, et al.. (2002). Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. Journal of Hepatology. 36(2). 263–270. 269 indexed citations

19.

Visser, Maaike, et al.. (2001). [Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections].. PubMed. 14(3). 269–74. 1 indexed citations

20.

Bonino, Ferruccio, Filippo Oliveri, P. Colombatto, et al.. (1999). Treatment of patients with chronic hepatitis C and cirrhosis. Journal of Hepatology. 31. 197–200. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact